News
Pfizer introduces new medicines optimisation scratch card
US-based Pfizer has introduced a new scratch card in a bid to involve the public in medicines optimisation. The card has been designed to increase patient engagement with the pharmacy team and create opportunities to...
News
Johnson & Johnson to acquire Alios BioPharma for $1.75bn
US-based Johnson & Johnson has signed an agreement to acquire a privately held clinical stage biopharmaceutical company, Alios BioPharma, for $1.75bn in cash. Based in California, US, Alios develops therapies for the treatment of...
News
In US, FedEx faces drug trafficking charges
The courier firm FedEx faces drug-trafficking charges after being indicted by a federal grand jury in California, in a case that highlights the growth in illegal online pharmacies selling dubious medication to people without prescription. The...
News
AIDS can be brought under control by 2030: UNAIDS
AIDS can be brought under control by 2030, according to a report by the United Nations Aids agency. It said the number of new HIV infections and deaths from Aids were both falling. At present,...
News
Shire open to AbbVie’s upped offer of £31 billion
AbbVie has now laid on the table a bid of £53.20 a share to acquire UK-headquartered Shire, up from last week’s offer of £51.15. Shire confirmed this morning that following talks it requested, and received, a...
News
Abbott to sell its developed markets branded generics pharma business to Mylan
The business to be sold operates in Europe, Japan, Canada, Australia and New Zealand and includes approximately 3,800 employees Abbott will sell its developed markets branded generics pharmaceuticals business to Mylan for equity ownership of a...
News
Glenmark Generics receives final ANDA approval for Telmisartan tablets
Telmisartan is Glenmark’s generic version of Boehringer Ingelheim’s Micardis Glenmark Generics Inc., US a subsidiary of Glenmark Generics Limited has been granted final abbreviated new drug approval (ANDA) from the United States Food and Drug Administration...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
















